{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:46:06Z","timestamp":1790682366177,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s10753-015-0220-3","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T07:18:28Z","timestamp":1438240708000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes"],"prefix":"10.1007","volume":"39","author":[{"given":"Hui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-mei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ru","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"key":"220_CR1","first-page":"765","volume":"42","author":"J Charles","year":"2013","unstructured":"Charles, J., H. Britt, and Y. Pan. 2013. Rheumatoid arthritis. Australian Family Physician 42: 765.","journal-title":"Australian Family Physician"},{"key":"220_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok, B., and G.S. Firestein. 2010. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Reviews 233: 233\u201355.","journal-title":"Immunological Reviews"},{"key":"220_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tips.2015.02.001","volume":"36","author":"MI Koenders","year":"2015","unstructured":"Koenders, M.I., and W.B. van den Berg. 2015. Novel therapeutic targets in rheumatoid arthritis. Trends in Pharmacological Sciences 36: 189\u2013195.","journal-title":"Trends in Pharmacological Sciences"},{"key":"220_CR4","first-page":"2777","volume":"27","author":"N Maruyama","year":"2000","unstructured":"Maruyama, N., F. Hirano, N. Yoshikawa, K. Migita, K. Eguchi, and H. Tanaka. 2000. Thrombin stimulates cell proliferation in human fibroblast-like synoviocytes in nuclear factor-kappaB activation and protein kinase C mediated pathway. Journal of Rheumatology 27: 2777\u201385.","journal-title":"Journal of Rheumatology"},{"key":"220_CR5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3899\/jrheum.100299","volume":"38","author":"Y Mei","year":"2011","unstructured":"Mei, Y., Y. Zheng, H. Wang, J. Gao, D. Liu, Y. Zhao, and Z. Zhang. 2011. Arsenic trioxide induces apoptosis of fibroblast-like synoviocytes and represents antiarthritis effect in experimental model of rheumatoid arthritis. Journal of Rheumatology 38: 36\u201343.","journal-title":"Journal of Rheumatology"},{"key":"220_CR6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bcp.2014.10.017","volume":"92","author":"L Verstrepen","year":"2014","unstructured":"Verstrepen, L., and R. Beyaert. 2014. Receptor proximal kinases in NF-\u03baB signaling as potential therapeutic targets in cancer and inflammation. Biochemical Pharmacology 92: 519\u201329.","journal-title":"Biochemical Pharmacology"},{"key":"220_CR7","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","volume":"27","author":"RL Piekarz","year":"2009","unstructured":"Piekarz, R.L., R. Frye, M. Turner, J.J. Wright, S.L. Allen, M.H. Kirschbaum, J. Zain, H.M. Prince, J.P. Leonard, L.J. Geskin, C. Reeder, D. Joske, W.D. Figg, E.R. Gardner, S.M. Steinberg, E.S. Jaffe, M. Stetler-Stevenson, S. Lade, A.T. Fojo, and S.E. Bates. 2009. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. Journal of Clinical Oncology 27: 5410\u20137.","journal-title":"Journal of Clinical Oncology"},{"key":"220_CR8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2007-06-098061","volume":"111","author":"G Garcia-Manero","year":"2008","unstructured":"Garcia-Manero, G., H. Yang, C. Bueso-Ramos, A. Ferrajoli, J. Cortes, W.G. Wierda, S. Faderl, C. Koller, G. Morris, G. Rosner, A. Loboda, V.R. Fantin, S.S. Randolph, J.S. Hardwick, J.F. Reilly, C. Chen, J.L. Ricker, J.P. Secrist, V.M. Richon, S.R. Frankel, and H.M. Kantarjian. 2008. Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood 111: 1060\u20136.","journal-title":"Blood"},{"key":"220_CR9","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","volume":"27","author":"AA Lane","year":"2009","unstructured":"Lane, A.A., and B.A. Chabner. 2009. Histone deacetylase inhibitors in cancer therapy. Journal of Clinical Oncology 27: 5459\u201368.","journal-title":"Journal of Clinical Oncology"},{"key":"220_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/dd945f7c-c50b-461d-ab38-15e8b0966458","volume":"8","author":"S Chen","year":"2013","unstructured":"Chen, S., Y. Zhao, W.F. Gou, S. Zhao, Y. Takano, and H.C. Zheng. 2013. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells. PloS One 8, e79781.","journal-title":"PloS One"},{"key":"220_CR11","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1158\/1078-0432.CCR-05-0344","volume":"11","author":"P Bali","year":"2005","unstructured":"Bali, P., M. Pranpat, R. Swaby, W. Fiskus, H. Yamaguchi, M. Balasis, K. Rocha, H.G. Wang, V. Richon, and K. Bhalla. 2005. Activity of suberoylanilide hydroxamic acid against human breast cancer cells with amplification of her-2. Clinical Cancer Research 11: 6382\u20139.","journal-title":"Clinical Cancer Research"},{"key":"220_CR12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3892\/ijo.2014.2337","volume":"44","author":"BR You","year":"2014","unstructured":"You, B.R., and W.H. Park. 2014. Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels. International Journal of Oncology 44: 1745\u201355.","journal-title":"International Journal of Oncology"},{"key":"220_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jfda.2014.01.005","volume":"22","author":"PP Fu","year":"2014","unstructured":"Fu, P.P., Q. Xia, H.M. Hwang, P.C. Ray, and H. Yu. 2014. Mechanisms of nanotoxicity: generation of reactive oxygen species. Journal of Food and Drug Analysis 22: 64\u201375.","journal-title":"Journal of Food and Drug Analysis"},{"key":"220_CR14","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s10753-013-9616-0","volume":"36","author":"M Li","year":"2013","unstructured":"Li, M., X. Liu, X. Sun, Z. Wang, W. Guo, F. Hu, H. Yao, X. Cao, J. Jin, P.G. Wang, J. Shen, and Z. Li. 2013. Therapeutic effects of NK-HDAC-1, a novel histone deacetylase inhibitor, on collagen-induced arthritis through the induction of apoptosis of fibroblast-like synoviocytes. Inflammation 36: 888\u201396.","journal-title":"Inflammation"},{"key":"220_CR15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/1471-2407-14-373","volume":"14","author":"XD Xu","year":"2014","unstructured":"Xu, X.D., L. Yang, L.Y. Zheng, Y.Y. Pan, Z.F. Cao, Z.Q. Zhang, Q.S. Zhou, B. Yang, and C. Cao. 2014. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. B.M.C. Cancer 14: 373.","journal-title":"B.M.C. Cancer"},{"key":"220_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12264-012-1057-5","volume":"28","author":"S Snigdha","year":"2012","unstructured":"Snigdha, S., E.D. Smith, G.A. Prieto, and C.W. Cotman. 2012. Caspase-3 activation as a bifurcation point between plasticity and cell death. Neuroscience Bulletin 28: 14\u201324.","journal-title":"Neuroscience Bulletin"},{"key":"220_CR17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.intimp.2012.02.005","volume":"12","author":"ZJ Shi","year":"2012","unstructured":"Shi, Z.J., D.Y. Ouyang, J.S. Zhu, L.H. Xu, and X.H. He. 2012. Histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits anti-inflammatory activities through induction of mitochondrial damage and apoptosis in activated lymphocytes. International Immunopharmacology 12: 580\u20137.","journal-title":"International Immunopharmacology"},{"key":"220_CR18","first-page":"698","volume":"19","author":"YC Wang","year":"2014","unstructured":"Wang, Y.C., W.Z. Kong, L.H. Xing, and X. Yang. 2014. Effects and mechanism of suberoylanilide hydroxamic acid on the proliferation and apoptosis of human hepatoma cell line Bel-7402. Journal of BUON 19: 698\u2013704.","journal-title":"Journal of BUON"},{"key":"220_CR19","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00204-012-0906-3","volume":"86","author":"JM Mat\u00e9s","year":"2012","unstructured":"Mat\u00e9s, J.M., J.A. Segura, F.J. Alonso, and J. M\u00e1rquez. 2012. Oxidative stress in apoptosis and cancer: an update. Archives of Toxicology 86: 1649\u201365.","journal-title":"Archives of Toxicology"},{"key":"220_CR20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1159\/000373938","volume":"35","author":"C Yan","year":"2015","unstructured":"Yan, C., D. Kong, D. Ge, Y. Zhang, X. Zhang, C. Su, and X. Cao. 2015. Mitomycin C induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via a mitochondrial-mediated pathway. Cellular Physiology and Biochemistry 35: 1125\u201336.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"220_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cbi.2009.07.016","volume":"182","author":"GC Shin","year":"2009","unstructured":"Shin, G.C., C. Kim, J.M. Lee, W.S. Cho, S.G. Lee, M. Jeong, J. Cho, and K. Lee. 2009. Apigenin-induced apoptosis is mediated by reactive oxygen species and activation of ERK1\/2 in rheumatoid fibroblast-like synoviocytes. Chemico-Biological Interactions 182: 29\u201336.","journal-title":"Chemico-Biological Interactions"},{"key":"220_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12192-014-0533-4","volume":"20","author":"S Park","year":"2015","unstructured":"Park, S., J.A. Park, Y.E. Kim, S. Song, H.J. Kwon, and Y. Lee. 2015. Suberoylanilide hydroxamic acid induces ROS-mediated cleavage of HSP90 in leukemia cells. Cell Stress & Chaperones 20: 149\u201357.","journal-title":"Cell Stress & Chaperones"},{"key":"220_CR23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.celrep.2015.03.012","volume":"11","author":"CM Blakely","year":"2015","unstructured":"Blakely, C.M., E. Pazarentzos, V. Olivas, S. Asthana, J.J. Yan, I. Tan, G. Hrustanovic, E. Chan, L. Lin, D.S. Neel, W. Newton, K.L. Bobb, T.R. Fouts, J. Meshulam, M.A. Gubens, D.M. Jablons, J.R. Johnson, S. Bandyopadhyay, N.J. Krogan, and T.G. Bivona. 2015. NF-\u03baB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer. Cell Reports 11: 98\u2013110.","journal-title":"Cell Reports"},{"key":"220_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11010-013-1730-7","volume":"382","author":"DD Kao","year":"2013","unstructured":"Kao, D.D., S.R. Oldebeken, A. Rai, E. Lubos, J.A. Leopold, J. Loscalzo, and D.E. Handy. 2013. Tumor necrosis factor-\u03b1-mediated suppression of dual-specificity phosphatase 4: crosstalk between NF\u03baB and MAPK regulates endothelial cell survival. Molecular and Cellular Biochemistry 382: 153\u201362.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"220_CR25","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1073\/pnas.0607939103","volume":"103","author":"X Li","year":"2006","unstructured":"Li, X., and S.S. Makarov. 2006. An essential role of NF-kappaB in the \u201ctumor-like\u201d phenotype of arthritic synoviocytes. Proceedings of the National academy of Sciences of the United States of America 103: 17432\u20137.","journal-title":"Proceedings of the National academy of Sciences of the United States of America"},{"key":"220_CR26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jbspin.2011.01.004","volume":"78","author":"SK Kim","year":"2011","unstructured":"Kim, S.K., K.Y. Park, W.C. Yoon, S.H. Park, K.K. Park, D.H. Yoo, and J.Y. Choe. 2011. Melittin enhances apoptosis through suppression of IL-6\/sIL-6R complex-induced NF-\u03baB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis. Joint, Bone, Spine 78: 471\u20137.","journal-title":"Joint, Bone, Spine"},{"key":"220_CR27","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1158\/0008-5472.CAN-10-1634","volume":"70","author":"AG Buggins","year":"2010","unstructured":"Buggins, A.G., C. Pepper, P.E. Patten, S. Hewamana, S. Gohil, J. Moorhead, N. Folarin, D. Yallop, N.S. Thomas, G.J. Mufti, C. Fegan, and S. Devereux. 2010. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription. Cancer Research 70: 7523\u201333.","journal-title":"Cancer Research"},{"key":"220_CR28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/cdd.2009.38","volume":"16","author":"R Audo","year":"2009","unstructured":"Audo, R., B. Combe, B. Coulet, J. Morel, and M. Hahne. 2009. The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases. Cell Death and Differentiation 16: 1227\u201337.","journal-title":"Cell Death and Differentiation"},{"key":"220_CR29","doi-asserted-by":"crossref","unstructured":"Grabiec A.M., Angiolilli C., Hartkamp L.M., van Baarsen L.G., Tak P.P., Reedquist K.A. 2014. JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2014 May 8.","DOI":"10.1136\/annrheumdis-2013-203610"},{"key":"220_CR30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjp.0707165","volume":"150","author":"HS Lin","year":"2007","unstructured":"Lin, H.S., C.Y. Hu, H.Y. Chan, Y.Y. Liew, H.P. Huang, L. Lepescheux, E. Bastianelli, R. Baron, G. Rawadi, and P. Cl\u00e9ment-Lacroix. 2007. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. British Journal of Pharmacology 150: 862\u201372.","journal-title":"British Journal of Pharmacology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-015-0220-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-015-0220-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-015-0220-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T22:07:15Z","timestamp":1567030035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-015-0220-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1007\/s10753-015-0220-3","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}